DISH Network Corp.

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. bluebird bio shares rose 6.6% to $3.05 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 142.6% to $0.7399 after the company announced preclinical results from two in vivo studies evaluating the antitumor efficacy of PAS-004 in NRAS mutation cancer xenograft models. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 79.4% to $0.7538 on continued volatility after the company last week received notification for not meeting the deadline to file its financial reports for several periods in 2023. Jet.AI Inc. (NASDAQ: JTAI) climbed 66% to $2.7550. The company recently posted a narrower quarterly loss. Assure Holdings Corp. (NASDAQ: IONM) gained 69.9% to $0.5950. Intchains Group Limited (NASDAQ: ICG) rose 25.8% to $11.02. Professional Diversity Network, Inc. (NASDAQ: IPDN) rose 23.3% to $2.64. Minim, Inc. (NASDAQ: MINM) gained 20% to $3.7450. MorphoSys AG (NASDAQ: MOR) rose 17.4% to $8.28 as the company presented comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib at 65th American Society of Hematology Annual Meeting. The Cigna Group (NYSE: CI) shares gained 16.8% to $302.25. Cigna has withdrawn from its proposed merger with Humana Inc. (NYSE: HUM). Macy's, Inc. (NYSE: M) rose 16.4% to $20.24. An investor consortium has tabled a $5.8 billion bid to acquire Macy's, in an attempt to privatize the iconic department store chain. Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares rose 15.6% to $0.7421. Onconova Therapeutics' preclinical narazaciclib data at SABCS highlighted differentiated anti-tumor activity v. other CDK4/6i's. Dogness (International) Corporation ...

Related tickers: COMM, BTBT, HIVE, IKT, MOR, VAPO, MINM, ROI, NIR, ISUN, DISH, SHAK, BMEA, CI, BPMC, TRKA, CYN, CLSK, NXTP, GIL, KOD, EFTR, HUM, CYTO, KTTA, M, VERU, IONM, WULF, ICG, ZLAB, JTAI, GGE, RIOT, CDT, IPDN, APLS, AAGR, MARA, DOGZ, BLUE, XFOR, ONTX, KROS.

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session. Cogent Biosciences, Inc. (NASDAQ: COGT) shares tumbled 52.7% to $4.0803 after the company reported initial data from its ongoing Phase 2 SUMMIT trial and data from Part 1 of its ongoing Phase 2 APEX clinical at ASH 2023. Biomea Fusion, Inc. (NASDAQ: BMEA) shares dipped 32.2% to $11.40 after the company announced it presented data for BMF-219 in relapsed / refractory AML patients with menin-dependent mutations at the ASH 2023 Annual Meeting. XBP Europe Holdings, Inc. (NASDAQ: XBP) fell 25% to $12.00. Keros Therapeutics, Inc. (NASDAQ: KROS) declined ...

Related tickers: KROS, BMEA, XPOF, COGT, XBP, COIN, DISH, SMRT, GIL, MARA, RNG, HIVE, CLSK, TELL, ZLAB, RIOT, APLS.